A detailed history of Metis Global Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Metis Global Partners, LLC holds 59,226 shares of BSX stock, worth $5.33 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
59,226
Previous 56,978 3.95%
Holding current value
$5.33 Million
Previous $4.39 Million 13.13%
% of portfolio
0.16%
Previous 0.15%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$72.96 - $84.0 $164,014 - $188,832
2,248 Added 3.95%
59,226 $4.96 Million
Q2 2024

Aug 06, 2024

BUY
$67.33 - $77.71 $33,530 - $38,699
498 Added 0.88%
56,978 $4.39 Million
Q1 2024

May 06, 2024

SELL
$57.6 - $68.62 $26,841 - $31,976
-466 Reduced 0.82%
56,480 $3.87 Million
Q4 2023

Feb 06, 2024

SELL
$48.64 - $57.81 $211,292 - $251,126
-4,344 Reduced 7.09%
56,946 $3.29 Million
Q3 2023

Nov 07, 2023

BUY
$50.19 - $54.68 $294,866 - $321,245
5,875 Added 10.6%
61,290 $3.24 Million
Q2 2023

Aug 07, 2023

BUY
$49.72 - $54.64 $10,043 - $11,037
202 Added 0.37%
55,415 $3 Million
Q1 2023

May 08, 2023

BUY
$45.09 - $50.03 $672,472 - $746,147
14,914 Added 37.01%
55,213 $2.76 Million
Q4 2022

Feb 07, 2023

BUY
$39.56 - $47.22 $574,173 - $685,351
14,514 Added 56.29%
40,299 $1.87 Million
Q3 2022

Nov 08, 2022

BUY
$36.71 - $109.66 $69,161 - $206,599
1,884 Added 7.88%
25,785 $1 Million
Q2 2022

Aug 08, 2022

BUY
$35.24 - $47.1 $48,631 - $64,998
1,380 Added 6.13%
23,901 $891,000
Q1 2022

May 03, 2022

BUY
$40.9 - $45.1 $413,212 - $455,645
10,103 Added 81.36%
22,521 $998,000
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $472,753 - $557,195
12,418 New
12,418 $528,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Metis Global Partners, LLC Portfolio

Follow Metis Global Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.